595 related articles for article (PubMed ID: 26633462)
1. Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions.
Kim J; Hall RR; Lesniak MS; Ahmed AU
Viruses; 2015 Nov; 7(12):6200-17. PubMed ID: 26633462
[TBL] [Abstract][Full Text] [Related]
2. Crossing the boundaries: stem cells and gene therapy.
Ferguson SD; Ahmed AU; Thaci B; Mercer RW; Lesniak MS
Discov Med; 2010 Mar; 9(46):192-6. PubMed ID: 20350484
[TBL] [Abstract][Full Text] [Related]
3. Directing systemic oncolytic viral delivery to tumors via carrier cells.
Nakashima H; Kaur B; Chiocca EA
Cytokine Growth Factor Rev; 2010; 21(2-3):119-26. PubMed ID: 20226717
[TBL] [Abstract][Full Text] [Related]
4. Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.
Park GT; Choi KC
Oncotarget; 2016 Sep; 7(36):58684-58695. PubMed ID: 27494901
[TBL] [Abstract][Full Text] [Related]
5. The utility of cells as vehicles for oncolytic virus therapies.
Russell SJ; Peng KW
Curr Opin Mol Ther; 2008 Aug; 10(4):380-6. PubMed ID: 18683103
[TBL] [Abstract][Full Text] [Related]
6. Employing RNA viruses to fight cancer: novel insights into oncolytic virotherapy.
Masemann D; Boergeling Y; Ludwig S
Biol Chem; 2017 Jul; 398(8):891-909. PubMed ID: 28441138
[TBL] [Abstract][Full Text] [Related]
7. Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer.
Power AT; Bell JC
Mol Ther; 2007 Apr; 15(4):660-5. PubMed ID: 17264852
[TBL] [Abstract][Full Text] [Related]
8. Maintaining and loading neural stem cells for delivery of oncolytic adenovirus to brain tumors.
Ahmed AU; Ulasov IV; Mercer RW; Lesniak MS
Methods Mol Biol; 2012; 797():97-109. PubMed ID: 21948472
[TBL] [Abstract][Full Text] [Related]
9. Virus combinations and chemotherapy for the treatment of human cancers.
Kumar S; Gao L; Yeagy B; Reid T
Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
[TBL] [Abstract][Full Text] [Related]
10. Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers.
Draganov DD; Santidrian AF; Minev I; Nguyen D; Kilinc MO; Petrov I; Vyalkova A; Lander E; Berman M; Minev B; Szalay AA
J Transl Med; 2019 Mar; 17(1):100. PubMed ID: 30917829
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.
Guo ZS; Thorne SH; Bartlett DL
Biochim Biophys Acta; 2008 Apr; 1785(2):217-31. PubMed ID: 18328829
[TBL] [Abstract][Full Text] [Related]
12. Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.
Zhang B; Cheng P
Mol Cancer; 2020 Nov; 19(1):158. PubMed ID: 33172438
[TBL] [Abstract][Full Text] [Related]
13. A mathematical model of oncolytic virotherapy with time delay.
Wang ZZ; Guo ZM; Smith H
Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
[TBL] [Abstract][Full Text] [Related]
14. Viruses as nanomedicine for cancer.
Badrinath N; Heo J; Yoo SY
Int J Nanomedicine; 2016; 11():4835-4847. PubMed ID: 27703350
[TBL] [Abstract][Full Text] [Related]
15. Potential of tumour cells for delivering oncolytic viruses.
Raykov Z; Rommelaere J
Gene Ther; 2008 May; 15(10):704-10. PubMed ID: 18356816
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
[TBL] [Abstract][Full Text] [Related]
17. United virus: the oncolytic tag-team against cancer!
Le Boeuf F; Bell JC
Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
[TBL] [Abstract][Full Text] [Related]
18. [Oncolytic adenoviruses in anti-cancer therapy: current status and perspectives].
Sviatchenko VA; Tarasova MV; Netesov SV; Chumakov PM
Mol Biol (Mosk); 2012; 46(4):556-69. PubMed ID: 23113343
[TBL] [Abstract][Full Text] [Related]
19. Virus, Oncolytic Virus and Human Prostate Cancer.
Liu GB; Zhao L; Zhang L; Zhao KN
Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
[TBL] [Abstract][Full Text] [Related]
20. Design of virotherapy for effective tumor treatment.
Garcia-Aragoncillo E; Hernandez-Alcoceba R
Curr Opin Mol Ther; 2010 Aug; 12(4):403-11. PubMed ID: 20677091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
